Galcanezumab
ATC N02CD02 · 9 markets · 19 records
AU 4 records · 3 strengths
- 120 mg/1 mLinjectionEMGALITY
- 120 mg/mLinjectionEMGALITY galcanezumab 120mg/mL prefilled penEMGALITY galcanezumab 120mg/mL prefilled syringe
Records without a stated strength · 1 EMGALITY
US 3 records · 2 strengths
CA 3 records · 2 strengths
SG 2 records · 2 strengths
- 120 mg/mLinjectionEMGALITY SOLUTION FOR INJECTION IN PRE-FILLED PEN 120 MG/ML
- 100 mg/mLinjectionEMGALITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100 MG/ML
TW 2 records · 2 strengths
- 100 mginjectionEMGALITY injection 100mg/mL恩疼停注射劑 100毫克/毫升
Records without a stated strength · 1 EMGALITY、恩疼停 注射劑
GB 1 records · 1 strengths
- 120 mg/1 mLinjectionEmgality 120mg/1ml solution for injection pre-filled pens
ES 1 records · 1 strengths
- 120 mg/1 mLinjectionEMGALITY PRECARGADA
HK 1 records · 1 strengths
Records without a stated strength · 1 EMGALITY SOLUTION FOR INJECTION IN PREFILLED PEN 120MG/1ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 EMGALITY
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 120 mg/1 mL injection | Emgality 120mg/1ml solution for injection pre-filled pens | EMGALITY | EMGALITY PRECARGADA | ||||||
| 120 mg/mL injection | EMGALITY galcanezumab 120mg/mL prefilled pen EMGALITY galcanezumab 120mg/mL prefilled syringe | EMGALITY SOLUTION FOR INJECTION IN PRE-FILLED PEN 120 MG/ML | |||||||
| 100 mg injection | EMGALITY | EMGALITY injection 100mg/mL 恩疼停注射劑 100毫克/毫升 | |||||||
| 120 mg liquid | EMGALITY | ||||||||
| 100 mg liquid | EMGALITY | ||||||||
| 120 mg injection | EMGALITY | ||||||||
| 100 mg/mL injection | EMGALITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100 MG/ML | ||||||||
unknown | EMGALITY | EMGALITY SOLUTION FOR INJECTION IN PREFILLED PEN 120MG/1ML | EMGALITY | ||||||
injection | EMGALITY 恩疼停 注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 CA · SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.